Simplex Trading
GTBP icon

Simplex Trading’s GT Biopharma GTBP Stock Holding History

Simplex Trading’s Portfolio GTBP Stock Details GTBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-10
Closed – – 9240
2023
Q4 		$0 Sell
10
-5
-33% -$37 ﹤0.01% 9191
2023
Q3 		$0 Buy
15
+2
+15% +$17 ﹤0.01% 9084
2023
Q2 		$0 Buy
+13
New +$135 ﹤0.01% 9336
2023
Q1 		– Sell
-9
Closed – – 9427
2022
Q4 		$0 Sell
9
-24
-73% -$1.2K ﹤0.01% 9636
2022
Q3 		$1K Sell
33
-31
-48% -$2.37K ﹤0.01% 9544
2022
Q2 		$5K Sell
64
-126
-66% -$9.55K ﹤0.01% 8826
2022
Q1 		$16K Sell
190
-20
-10% -$1.76K ﹤0.01% 8459
2021
Q4 		$19K Buy
210
+208
+10,400% +$31.1K ﹤0.01% 8401
2021
Q3 		$1K Hold
2
– – ﹤0.01% 9640
2021
Q2 		$1K Buy
+2
New +$831 ﹤0.01% 9817

Other funds holding GTBP

Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Simplex Trading's GTBP Position: Q1 2024 in Review

Simplex Trading sold out of GT Biopharma (GTBP) in Q1 2024, closing a stake of 10 shares.

Simplex Trading first reported a position in GTBP in Q2 2021 and held it in 10 quarters. The position peaked at $19K in Q4 2021. 17 funds tracked by Wall St. Rank hold GTBP as of Q1 2024.

  • Simplex Trading reported no remaining GT Biopharma position as of Q1 2024 after selling out during the quarter.
  • Simplex Trading sold 10 GT Biopharma shares in Q1 2024.
  • Simplex Trading first reported a position in GT Biopharma in Q2 2021 and held it in 10 quarters.
  • Simplex Trading's GT Biopharma position peaked at $19K in Q4 2021.
  • 17 funds tracked by Wall St. Rank held GT Biopharma as of Q1 2024.

Based on Simplex Trading's 13F filing for Q1 2024, filed 25 Apr 2024.